Taiwan Liposome Company, Ltd (TLC)

Trade TLC now with
4/15/2019 5:03:34 AM TLC Reports Positive End-of-Phase II Meeting With FDA For TLC599
4/8/2019 5:09:04 AM TLC Reports Full Enrollment In Part 1 Of Phase II Trial Of TLC590
3/18/2019 5:04:34 AM TLC Announces First Patient Dosed In Phase II Trial Of TLC590 For Postsurgical Pain Management Following Bunionectomy
1/25/2019 3:57:18 AM TLC Appoints George Spencer-Green As Chief Medical Officer
1/22/2019 6:02:12 AM Taiwan Liposome: EMA Grants Orphan Drug Designation To TLC178 For Treatment Of Soft Tissue Sarcoma